← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2004Last known activity
Nov 1, 2010
Acquired by Aralez Pharmaceuticals on Dec 1, 2015
Timeline
1990s
- Jul 1, 1996
POZEN— Founded
2010s
- Dec 1, 2015
Aralez Pharmaceuticals— Acquired By
Drugs by trial phase (11 distinct, 30 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (43)
- NCT01557335Study directorPhase 1Nov 1, 2010
- NCT01557335Lead sponsorPhase 1Nov 1, 2010
- NCT01094483CollaboratorPhase 1Mar 1, 2010
- NCT00961350Lead sponsorPhase 3Oct 1, 2009
- NCT00960869Lead sponsorPhase 3Oct 1, 2009
- NCT00995410Lead sponsorPhase 3Oct 1, 2009
- NCT00992381CollaboratorPhase 1Sep 1, 2009
- NCT00749385Lead sponsorPhase 1Aug 1, 2008
- NCT00729495Lead sponsorPhase 1Jul 1, 2008
- NCT00700687Lead sponsorPhase 1Jun 1, 2008
- NCT00692055Lead sponsorPhase 1Jun 1, 2008
- NCT00676442Lead sponsorPhase 1May 1, 2008
- NCT00665431Lead sponsorPhase 3Apr 1, 2008
- NCT00664560Lead sponsorPhase 3Apr 1, 2008
- NCT00665431Study chairPhase 3Apr 1, 2008
Details
- Founded
- Chapel Hill, NC, US Jul 1, 1996
- Last known activity
- Nov 1, 2010
Notes
Acquired by Aralez Pharmaceuticals in 2015